Clinical Trials for NX Development

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NX Development

Clinical Trials (3)

NCT06907485
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
PHASE2Not yet recruiting
20 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2027
1 condition7 sponsors2 locations
NCT07038278
5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
EARLY_PHASE1Not yet recruiting
20 participants
Started: Dec 1, 2025 · Completed: Jul 1, 2028
1 condition2 sponsors1 location
NCT05804370
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
PHASE3Recruiting
170 participants
Started: May 30, 2024 · Completed: May 31, 2027
1 condition1 sponsor6 locations